Search

everythinglearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Bitter melon extract may help prevent hair loss and can be used in cosmetic products.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Certain immune cells in the skin can stop hair from growing.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

A new method using a microfluidic device can prepare hair follicle germs efficiently for potential use in hair loss treatments.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Ginsenoside Rd may help improve skin aging by increasing collagen in the skin.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.

Finasteride helps female-pattern hair loss.

Type I interferons play a key role in the development of various skin diseases.

Troxerutin helps protect skin cells from oxidative stress and may be good for treating hair loss.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.